Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 1/2 1

Status

Terminated 9Completed 5Recruiting 2Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 7OTHER 5NIH 3

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 2Thoracic 1Other solid neoplasm 1Head & Neck 1Gastrointestinal 1

Conditions

Neoplasm Metastasis 2Recurrence 1Rectal Neoplasms 1Nasopharyngeal Carcinoma 1Microsatellite Instability 1Mesothelioma, Malignant 1Mesothelioma 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 328Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 280Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × OTHER × bintrafusp alfa protein, human × Clear all
NCT05005429 2025-12-23

BIMES

Fundación GECP

Phase 2 Completed
47 enrolled 9 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT03436563 2024-11-27

M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability

M.D. Anderson Cancer Center

Phase 1/2 Completed
4 enrolled 7 charts
Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms, Microsatellite Instability

NCT03620201 2024-10-22

M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
20 enrolled
Breast

Anatomic Stage II Breast Cancer AJCC v8

NCT04396886 2024-05-09

Bintrafusp Alfa in Previously Treated Patients With R/M Non-keratinizing NPC

The University of Hong Kong

Phase 2 Completed
38 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

NCT03524170 2022-03-07

Radiation Therapy and M7824 in Treating Patients With Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
24 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡